The use of cannabidiol (CBD) for therapeutic purposes is receiving considerable attention,
with speculation that CBD can be useful in a wide range of conditions. Only one product, a …

Background Medical cannabinoids differ in their pharmacology and may have different
treatment effects. We aimed to conduct a pharmacology-based systematic review (SR) and …

Background: Human navigation of social interactions relies on the processing of emotion on
faces. This meta-analysis aimed to produce an updated brain atlas of emotional face …

The pharmacological interventions available for individuals in the early stages of psychosis
are extremely limited. For those at clinical high risk for psychosis, there is no licensed …

Although alcohol use disorder (AUD) is highly prevalent, only a few medications are
approved for its treatment leaving much room for improvement. Cannabidiol (CBD) might be …

Schizophrenia and autism spectrum disorders (ASD) are psychiatric neurodevelopmental
disorders that cause high levels of functional disabilities. Also, the currently available …

Social anxiety disorder (SAD) is a debilitating disorder, characterized by fear and anxiety in
social situations. Evidence suggests that the levels of SAD are rising, in particularly after the …

Background Acupuncture of PC6 points has the effects of calming, tranquilizing, regulating
qi, and relieving pain and has been clinically found to alleviate anxiety disorders. To explore …

The current review evaluates the potential of cannabidiol (CBD) as a promising
pharmacotherapy for social anxiety disorder (SAD). Although a number of evidence-based …

Evidence suggests that people at Clinical High Risk for Psychosis (CHR) have a blunted
cortisol response to stress and altered mediotemporal activation during fear processing …